Welcome to our searchable resource and literature collection on safer supply and related topics.

Found a broken link? Links do move around, so if you find one here that's broken, please let us know through the Contact form.

Guidelines | 2022
About prescribers, Substitution/OAT, Hospitals, Clinical guidance
Guide or handbook | 2022
Clinical guidance, Harm reduction, Policy/Regulatory, Safer supply, About prescribers

The objective of this analysis was to measure rates of follow-up and use of medications for OUD (MOUD) after residential treatment among Medicaid enrollees in 10 states, and to understand the enrol

Original research | 2022
Transitions in care/treatment, Substitution/OAT, Wrap-around services

Health Canada conditionally approves new drugs using its Notice of Compliance with conditions (NOC/c) policy.

Original research | 2022
Letter | 2022
Safer supply, About prescribers, Policy/Regulatory, Overdose

Racial/ethnic minorities have experienced disproportionate opioid-related overdose death rates in recent years.

Original research | 2022
Overdose, Harm reduction, Equity

Buprenorphine is an effective medication for the treatment of opioid use disorder (OUD), but the association between prior authorization policies and quality of care for individuals receiving bupre

Original research | 2022
Policy/Regulatory, Substitution/OAT

To estimate the association between buprenorphine treatment gaps, opioid overdose, and health care spending.

Original research | 2022
Overdose, Substitution/OAT, About PWUD

The objectives of this study were to assess the prevalence and correlates of naloxone administration by police, as well as to examine overdose events where arrests were made and those in which the

Original research | 2022
Justice system/law enforcement, Overdose

We examined the impact of U.S. state opioid-prescribing policies on opioid overdose mortality following implementation.

Original research | 2022
About prescribers, Mortality, Policy/Regulatory, Justice system/law enforcement

We sought to examine the relationship between OAT engagement and crystal methamphetamine use and to assess if this relationship differs according to the ongoing use of unregulated opioids.

Original research | 2022
Substitution/OAT, Stimulants, Illegal drugs, About PWUD, Transitions in care/treatment

This study explores how living with multiple stigmatized identities impacts substance use recovery among people with a migration background and ethnic minorities (MEM).

Original research | 2022
Equity, Stigma

Intravenous buprenorphine for the treatment of OUD (BUP iOAT) has several possible advantages over traditional iOAT, including a safety profile that might enable take-home dosing.

Lit review | 2022
Injecting drugs, Substitution/OAT

Our aim was to publish an interactive summary of all peer-reviewed interventional and observational trials assessing the treatment of OUD and common clinical outcomes.

Original research | 2022
Substitution/OAT, Evidence base

The COVID-19 pandemic has impacted supervised consumption site (SCS) operations in Montréal, Canada, potentially including changes in SCS visits, on-site emergency interventions, injection of speci

Original research | 2022
SCS/OPS, Overdose, Illegal drugs
Guide or handbook | 2022
SCS/OPS, About prescribers, Wrap-around services, Justice system/law enforcement, Policy/Regulatory, Illegal drugs
Training | 2022
Mental health, Workplace, Peer/PWLLE program involvement

The present study was conducted to estimate the association between measures of hope for the future and time to substance use relapse among people living with opioid dependence following their disc

Original research | 2022
About PWUD, Mental health

In this study, we describe the drug use practices — including access to and use of on-site supervised consumption, OAT, and prescribed safer supply medications — of study participants living in per

Original research | 2022
Housing, SCS/OPS, About PWUD, Safer supply, Evidence base, Wrap-around services, Crime

The rapid increase in fentanyl overdose deaths, particularly those also attributed to stimulants, has led to concerns about unintentional fentanyl exposure.

Original research | 2022
Overdose, Mortality, About PWUD

Refine Your Search